Skip to content

King & Wood Mallesons Pulse

  • Topics
    • All Topics
    • Carbon markets
    • Competition & consumer
    • Consumer protection
    • ESG
    • Future energy
    • Hydrogen
    • Inhouse Counsel
    • International Arbitration
    • Intellectual Property
    • Technology
  • Jurisdictions
    • Australia
    • China
    • Hong Kong
    • Singapore
    • Global
  • Specialty Blogs
    • In Competition
    • International Arbitration
    • IP Whiteboard
  • Authors

King & Wood Mallesons Pulse

  • Topics
    • All Topics
    • Carbon markets
    • Competition & consumer
    • Consumer protection
    • ESG
    • Future energy
    • Hydrogen
    • Inhouse Counsel
    • International Arbitration
    • Intellectual Property
    • Technology
  • Jurisdictions
    • Australia
    • China
    • Hong Kong
    • Singapore
    • Global
  • Specialty Blogs
    • In Competition
    • International Arbitration
    • IP Whiteboard
  • Authors

gene patents

Is the cure in your DNA? – The rise of biopharmaceuticals and pharmacogenomics-led therapy

Is the cure in your DNA? – The rise of biopharmaceuticals and pharmacogenomics-led therapy

4 June 2018
By Veg Tran
15 years has passed since the Human Genome Project, involving the identification and mapping of all the genes of the human genome, was declared complete.
Read on
High Court re-invents the test for patentable subject matter and finds the patent for the isolated breast cancer gene invalid

High Court re-invents the test for patentable subject matter and finds the patent for the isolated breast cancer gene invalid

8 October 2015
By David Fixler
The High Court has handed down a significant decision finding that patent claims for isolated gene sequences, indicative of a predisposition to breast cancer, are not patentable subject matter.
Read on
High Court grants Application for Special Leave to Appeal in Myriad Genetics

High Court grants Application for Special Leave to Appeal in Myriad Genetics

13 February 2015
By Suzy Madar
The High Court has granted Cancer Voices’ application for special leave to appeal a Full Federal Court finding that Myriad’s patent relating to the BRCA1 gene is patentable.
Read on
Isolated genes patentable: Cancer Voices Australia v Myriad Genetics

Isolated genes patentable: Cancer Voices Australia v Myriad Genetics

5 September 2014
By Tom Naylor
BREAKING NEWS: Full Federal Court finds that isolated genetic material is patentable subject matter as an artificially created state of affairs.
Read on
Just genes? Lessons from the Myriad litigation

Just genes? Lessons from the Myriad litigation

19 August 2013
By James Ellsmore
gene patents, patentability, myriad litigation
Read on

Speciality Blogs

  • In Competition
  • International Arbitration
  • IP Whiteboard

More From IP Whiteboard

  • IP Whiteboard

Trending Topics

  • Dispute resolution & litigation
  • Hong Kong
  • Litigation
  • Technology
View All Topics

Most Viewed

Bilateral relations for Australia & China enter a new chapter

Read More

ASIC flexes muscles in scam and phishing takedowns

Read More
King & Wood Mallesons
©2026 King & Wood Mallesons

Follow Us

  • LinkedIn
  • Facebook
  • Twitter
Subscribe to KWM Pulse
Terms of use & legal notices | Privacy statement
©2026 King & Wood Mallesons